JP2009149624A5
(https= )
2010-03-04
PH12021550756A1
(en )
2022-02-21
Compositions and methods for treating and/or preventing cardiovascular disease
BRPI0719849A2
(pt )
2014-04-29
Método de imunização contra os quatro sorotipos da dengue
BRPI0911984A2
(pt )
2016-09-20
sequências de aminoácidos direncionadas contra cxcr4 e outros compostos gpcrs compreendendo os mesmos
CY1120888T1
(el )
2019-12-11
Διαδερμικες φαρμακευτικες συνθεσεις περιλαμβανοντας ενεργους παραγοντες
BRPI0718927A2
(pt )
2014-04-08
Método de imunização contra os quatro sorotipos da dengue.
IL251768B
(en )
2022-02-01
Auris formulations for treating otic diseases and conditions
BRPI0920030A2
(pt )
2015-12-15
agente de oclusão do tecido
BRPI0719594A2
(pt )
2014-02-18
Partícula de liberação contendo agente de benefício
CL2007002095A1
(es )
2008-01-18
Composicion farmaceutica topica que comprende 1-(2-metilpropil)-1h-imidazo[4,5-c]quinolin-4-amina; composicion empacada; metodo para esterilizarla; util para cicatrizar tejido donde la dermis se ha desgarrado.
EP2616003A4
(en )
2016-05-11
CLOSURE MEASUREMENT FOR THE DESIGN OF DENTAL PROSTHESIS
WO2009125409A3
(en )
2009-12-03
Fatty acid amides and uses thereof
WO2015028745A3
(fr )
2015-05-07
Composition cosmétique comprenant un polymère sulfonique, un polysaccharide hydrophobe et un tensioactif siliconé
EP2749582A4
(en )
2015-04-22
FLUOROUS COPOLYMER AND SURFACE MODIFICATOR THEREFOR AS ACTIVE SUBSTANCE
WO2009103959A3
(en )
2009-10-15
Histidine and/or histidine derivative for the treatment of inflammatory skin diseases
AU2007267997A8
(en )
2009-09-24
Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses
JP2013253067A5
(https= )
2016-04-21
WO2009100886A3
(en )
2009-11-26
Formulations of flibanserin
WO2011011706A3
(en )
2011-06-30
Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents
BRPI1003940B8
(pt )
2022-08-30
Composição para cuidado de saúde compreendendo um tensoativo polimerizado de baixo dp e um espessante micelar
EP2497566A4
(en )
2017-05-10
Polyfluoroalkyl phosphonate salt emulsifying agent and mold release agent comprising same as active ingredient
WO2007103751A3
(en )
2008-03-06
Release agents containing saponified fatty and rosin acids or derivatives thereof
WO2008051461A3
(en )
2008-07-31
Acne treatment composition and methods for using
WO2010025011A8
(en )
2010-09-30
Formulations of canfosfamide and their preparation
EP2077847A4
(en )
2014-04-30
HALOGENED ALKYLIC DIIS AND TRISACCHARIDES, PHARMACEUTICAL FORMULATIONS, DIAGNOSIS KITS, AND TREATMENT PROCEDURES